{{Rsnum
|rsid=10759
|Gene=RGS4
|Chromosome=1
|position=163076561
|Orientation=minus
|GMAF=0.2764
|Gene_s=RGS4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 8.0 | 39.3 | 52.7
| HCB | 22.6 | 45.3 | 32.1
| JPT | 11.6 | 47.3 | 41.1
| YRI | 0.7 | 20.4 | 78.9
| ASW | 0.0 | 26.3 | 73.7
| CHB | 22.6 | 45.3 | 32.1
| CHD | 21.5 | 47.7 | 30.8
| GIH | 14.1 | 42.4 | 43.4
| LWK | 0.0 | 16.4 | 83.6
| MEX | 7.3 | 45.5 | 47.3
| MKK | 0.7 | 16.3 | 83.0
| TSI | 3.0 | 44.6 | 52.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23529717
|Title=Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer
|OA=1
}}

{{PMID Auto
|PMID=17588543
|Title=Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.
|OA=1
}}

{{PMID Auto
|PMID=23332465
|Title=Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}